Lucie Lechevalier Hurard

Dr. Lucie Lechevalier Hurard


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2020 in Pharmacy
Verified
Journal Article
Open access
PDF file
RFRose-Anna Foley
Rose-Anna Foley
LHLucie Lechevalier Hurard
Lucie Lechevalier Hurard
DCDamien Cateau
Damien Cateau
DKDaria Koutaissoff
Daria Koutaissoff
OBOlivier Bugnon
Olivier Bugnon
ANAnne Niquille
Anne Niquille
Background: Polypharmacy and the use of potentially inappropriate medications are frequent safety issues among nursing home (NH) residents. Deprescribing can significantly reduce the number of drugs used, medication costs, and mortality. This qualitative study sought to understand and compare the perceptions and practices of nurses, pharmacists, and physicians regarding deprescribing in Swiss NHs, referring to an implementation approach on three levels of action: the individual, the institution, and the healthcare system. Methods: Two focus groups were held with 21 participants: one focus group with 11 pharmacists, another with 10 nurses and six semi-structured interviews with physicians were conducted and focused on their individual experience and practices. They were audiotaped and fully transcribed, and a content analysis was performed using to MAXQDA (Ver 12) software. Results: (1) At an individual level, physicians were concerned by consequences of deprescribing in terms of safety. Nurses were closest to residents and stressed the importance of finding the right time, creating a bond of trust before deprescribing and considering the purpose of the stay in the NH. Pharmacists relied on structured guides for deprescribing, which led their reflection and practice. All professionals saw the complexity of the clinical situations, as well as residents’ and relatives’ fears of interruption of care. (2) At an institutional level, the professionals stressed the lack of time to discuss patients’ health and treatment, while pre-existing interprofessional collaboration, specifically, quality circles, seemed useful tools to create common knowledge. In order to reduce prescriptions, better coordination between physicians, nurses, pharmacists and specialists seemed crucial. (3) At the health system level, funding still needs to be provided to consolidate the process, go beyond organisational constraints and ensure deprescribing serves the patient’s wellbeing above all. Conclusions: At the individual level of implementation, the different healthcare professionals expressed specific concerns about deprescribing, depending on their defined role in NHs. Their perspective about the different levers to promote deprescribing at institutional and healthcare system levels converge towards interprofessional collaboration supported by the healthcare system. Specific funding and incentives are therefore needed to support a sustainable interprofessional team.

19 March 2020 in Gérontologie et société
Verified
Journal Article
Open access
PDF file
LHLucie Lechevalier Hurard
Lucie Lechevalier Hurard
DCDamien Cateau
Damien Cateau
OBOlivier Bugnon
Olivier Bugnon
ANAnne Niquille
Anne Niquille
RFRose-Anna Foley
Rose-Anna Foley
Cet article est issu d’une recherche interdisciplinaire en pharmacie et sciences sociales sur la polymédication et la déprescription en maison de retraite menée en Suisse romande. Si les facteurs psycho-sociaux sont souvent mobilisés pour expliquer la difficile déprescription (réduction encadrée de la consommation de médicaments pour réduire ses effets délétères identifiés), les propos des usagers interviewés mettent en lumière les facteurs structurels du fonctionnement des établissements pour comprendre le phénomène de polymédication et sa persistence. Perdant leur autonomie sur beaucoup d’aspects de leur vie quotidienne, la plupart des résidents délèguent intégralement la gestion des médicaments aux professionnels et estiment ne plus vraiment avoir de prise sur l’évolution des prescriptions. L’enquête montre pourtant qu’entre recherche d’efficacité et crainte des effets secondaires, les usagers se révèlent perméables aux discours des professionnels et accessibles à la sensibilisation aux risques de la polymédication. L’article conclut sur des pistes qui pourraient faciliter une démarche de déprescription concertée, et favoriser le partage des décisions avec les résidents de maisons de retraite à partir du levier des consommations de médicaments.